NRx Pharmaceuticals

NRx Pharmaceuticals to Spotlight Ketamine’s Potential and Risks in Keynote Address at Sachs Neuroscience Innovation Forum

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has announced that it will present a keynote address at the highly anticipated Sachs Neuroscience Innovation Forum in San Francisco later today.

NRx Pharmaceuticals to Spotlight Ketamine’s Potential and Risks in Keynote Address at Sachs Neuroscience Innovation Forum Read More

NRx Pharmaceuticals

NRx Pharmaceuticals and Nephron Pharmaceuticals Announce Joint Agreement to Develop Intravenous Ketamine to Treat Suicidal Depression

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and Nephron Pharmaceuticals, Inc. announced the recent signing of a development and manufacturing agreement to manufacture a presentation of ketamine suitable for …

NRx Pharmaceuticals and Nephron Pharmaceuticals Announce Joint Agreement to Develop Intravenous Ketamine to Treat Suicidal Depression Read More

NRx Pharmaceuticals

NRx Pharmaceuticals Announces Signing of a Development Agreement for the Manufacture of Ketamine to Treat Suicidality and Depression

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently announced the signing of a development contract to manufacture a presentation of ketamine suitable for intravenous administration under current FDA manufacturing …

NRx Pharmaceuticals Announces Signing of a Development Agreement for the Manufacture of Ketamine to Treat Suicidality and Depression Read More
sad

Saving Lives: Pennsylvania Takes Action During Suicide Prevention Awareness Month, Enhances Mental Health Support Across Agencies

PENNSYLVANIA — Department of Human Services (DHS) Secretary Dr. Val Arkoosh, along with leaders from multiple state agencies and suicide prevention advocacy groups, this past week joined together to recognize …

Saving Lives: Pennsylvania Takes Action During Suicide Prevention Awareness Month, Enhances Mental Health Support Across Agencies Read More